Clinical Trial Update: Curcumin in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial of curcumin in patients with mild to moderate Alzheimer's disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: John Douglas French Foundation | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED